Stock A048530 INTRON BIOTECHNOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart iNtRON Biotechnology, Inc.

Equities

A048530

KR7048530000

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 13/06/2024 BST 		5-day change 1st Jan Change
5,720 KRW -1.21% Intraday chart for iNtRON Biotechnology, Inc. -6.84% -34.85%
03-13 INtRON Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
02-15 Intron Biotechnology, Inc. Announces New Drug Part Secures A Potent Anti-Cancer Candidate, PHAGERIA®, with Broad Antimicrobial Activity Against ETBF (Enterotoxigenic B. Fragilis), A Harmful Microbe Associated with Colorectal Cancer CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
INTRON BIOTECHNOLOGY, INC. Stock iNtRON Biotechnology, Inc.
 137M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 124B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 112B
ARGENX SE Stock argenx SE
 22.94B -
BIONTECH SE Stock BioNTech SE
 22.22B -
BEIGENE, LTD. Stock BeiGene, Ltd.
 17.02B -
  1. Stock Market
  2. Equities
  3. A048530 Stock
  4. Charts iNtRON Biotechnology, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW